Atea Pharmaceuticals (AVIR) Return on Equity (2020 - 2026)

Atea Pharmaceuticals' Return on Equity history runs 7 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.01% for Q1 2026 at Atea Pharmaceuticals, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2022 to a low of 0.01% in Q1 2026.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• Biggest YoY gain for Return on Equity was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2022, then sank by 35 bps to 0.0% in 2023, then plunged by 57 bps to 0.0% in 2024, then tumbled by 43 bps to 0.01% in 2025, then declined by 24 bps to 0.01% in 2026.
• The last three Return on Equity figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.